Why Psychiatric Claims Get Denied
Psychiatric practices face denial rates that are consistently higher than most medical specialties. The combination of behavioral health carve-outs, visit frequency restrictions, complex prior authorization requirements for medications, and ongoing credentialing challenges with multiple payer networks creates a denial landscape that requires specialty-specific management. The average psychiatric practice loses 8 to 12% of potential revenue to denials, and practices without dedicated denial management processes lose significantly more.
Medication Management Frequency Limits
Many payers impose limits on how often a patient can receive medication management services. Common restrictions include: no more than one E/M visit per month for stable patients, a maximum of 12 medication management visits per year, or requirements that visits be spaced at least 14 days apart. When a patient with treatment-resistant depression needs weekly medication adjustments during a titration period, claims beyond the frequency limit are denied even though the visits are medically necessary.
Appeal strategy: Document the clinical justification for increased visit frequency. Include the specific medication being titrated, the clinical response being monitored (symptom severity scores, side effect assessments), and the expected timeline for stabilization. Reference published treatment guidelines (APA Practice Guidelines) that support closer monitoring during medication changes. Request a peer-to-peer review with the payer medical director.
Prior Authorization Failures
Prior authorization denials in psychiatry fall into two categories: authorization not obtained before the service, and authorization request denied on clinical grounds. The first category is preventable through workflow improvements. The second requires clinical appeal. Common triggers for PA denials include prescribing a non-formulary antipsychotic without documented failure of formulary alternatives, requesting brand-name stimulants without trial of generic methylphenidate or amphetamine, and initiating clozapine without documented treatment resistance.
Appeal strategy: For services rendered without PA, submit a retrospective authorization request within the payer deadline (typically 30 to 60 days). Include documentation showing the service was urgent or emergent. For clinical PA denials, submit a letter of medical necessity with the patient diagnosis, treatment history, documented failures of alternative medications (including dates and reasons for discontinuation), and clinical rationale for the requested medication or service.
E/M Level Disputes
Payers frequently downcode psychiatric E/M visits from level 4 (99214) to level 3 (99213), reducing reimbursement by approximately $40 per visit. Downcoding occurs when documentation does not clearly support the medical decision-making complexity required for the billed level. In psychiatry, the clinical complexity is often higher than the documentation reflects because providers focus on the therapeutic interaction and understate the pharmacological complexity in their notes.
Appeal strategy: Submit the complete encounter note with a cover letter highlighting the specific elements that support the billed MDM level. For 99214, document: the number and complexity of problems addressed (multiple psychiatric conditions or medication management complexities), the amount of data reviewed (lab results, pharmacy records, outside records), and the risk of the management options (prescribing controlled substances, managing medications with serious side effect profiles, monitoring lithium or clozapine levels). Psychiatric visits involving suicidal ideation assessment, involuntary hold considerations, or complex polypharmacy decisions support level 4 or 5.
Credentialing Issues
Credentialing denials occur when the rendering provider is not enrolled with the specific behavioral health network that manages the patient plan. This is particularly common in psychiatry because behavioral health carve-outs maintain separate provider networks from the medical plan. A psychiatrist credentialed with United Healthcare medical network may not be credentialed with Optum Behavioral Health, even though Optum is a United subsidiary. Each carve-out requires a separate credentialing application.
Appeal strategy: For services rendered during a credentialing gap, submit a request for retroactive credentialing effective from the application date. Include proof of the credentialing application submission date. Some states have prompt-pay laws that require payers to process credentialing applications within 60 to 90 days and provide retroactive coverage if they exceed that timeline. Track credentialing timelines for each payer and escalate applications that exceed the regulatory deadline.
Medical Necessity Denials for Psychotherapy
Some payers deny psychotherapy claims (90834, 90837) when the diagnosis does not meet their internal criteria for therapy coverage, or when the patient has exceeded a session limit. Common denial triggers: therapy billed for adjustment disorders beyond 6 months, ongoing weekly therapy without documented treatment plan updates, and psychotherapy for conditions the payer considers requiring medication management only.
Appeal strategy: Submit treatment plan documentation showing measurable treatment goals, progress toward those goals, and the clinical rationale for continued therapy. Include validated outcome measures (PHQ-9, GAD-7, PCL-5) showing symptom severity that warrants continued treatment. Reference clinical practice guidelines supporting psychotherapy for the diagnosed condition.